Cidara Therapeutics Inc. | Ownership
Companies that own Cidara Therapeutics Inc.
Bellevue Asset Management AG
2,295,272
8.28%
0
0.14%
06/30/2018
BVF Partners LP
1,930,670
6.98%
1,930,670
0.55%
06/30/2018
Opaleye Management, Inc.
1,200,000
4.34%
1,200,000
1.29%
06/30/2018
Prosight Management LP
1,158,700
4.19%
-27,655
3.37%
06/30/2018
Fidelity Management & Research Co.
1,040,404
3.76%
-431,149
0%
08/31/2018
Millennium Management LLC
722,826
2.61%
133,163
0%
06/30/2018
The Vanguard Group, Inc.
572,719
2.06%
9,400
0%
06/30/2018
Monashee Investment Management LLC
480,851
1.74%
480,851
0.36%
06/30/2018
Granahan Investment Management, Inc.
455,994
1.65%
455,994
0.1%
06/30/2018
Stonepine Capital Management LLC
425,531
1.54%
425,531
1.04%
06/30/2018
| Address |
6310 Nancy Ridge Drive
San Diego California 92121
United States
|
|
Employees
|
- |
| Website |
http://www.cidara.com |
| Updated |
07/08/2019 |
| Cidara Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of anti-infectives for the treatment of fungal infections. Its portfolio includes CD101 IV, CD101 Topical, and Cloudbreak. The company was founded by Kevin M. |
